期刊文献+

红色荧光基因慢病毒转染人脑胶质瘤干细胞的实验研究 被引量:1

Labeling of stable glioma stem cells with red fluorescent protein transfected by lentiviral vector
原文传递
导出
摘要 目的建立体外稳定表达红色荧光蛋白(RFP)的人脑胶质瘤干细胞。方法将含有R印基因的慢病毒(RFP-lentivirus)转染体外培养的人脑胶质瘤干细胞SU2.荧光显微镜下观察红色荧光表达情况;流式细胞仪测定转染前SU2细胞、转染后IuP—SU2细胞传代培养20代后红色荧光转染率;动态观察IUP-SU2单细胞的分裂及克隆形成情况;免疫荧光染色检测RFP.SU2细胞CD133、nestin的表达。结果RFP-SU2呈悬浮球状生长,RFP呈高表达。转染前SU2细胞的红色荧光转染率仅为1.5%,转染并克隆培养20代后RFP—SU2细胞红色荧光转染率达75%。RFP—SU2单细胞仍可增殖形成脑肿瘤干细胞球,具有自我更新和克隆增殖能力。免疫荧光染色检测显示RFP.SU2细胞中CD133、nestin表达阳性。结论以RFP为生物标记物的人脑胶质瘤干细胞成功建立,可为将来人脑胶质瘤干细胞的深入研究提供理想的材料。 Objective To establish stable glioma stem cells with a high expression level of red fluorescent protein (KFP) in vitro. Methods The glioma stem cells SU2 were transfected with lentivirus vector containing IFP gene; cell expression of RFP was observed by fluorescent microscopy; RFP-positive glioma stem cells were sorted out by fluorescence-activated cell sort. The transfection efficiency of SU2 cell before transfection and 20-passaged RFP-SU2 cells after tmnsfection were assayed by flow cytometry. Dynamic viewing was performed to observe the cell division and cloning of RFP-SU2 single cell; RFP -positive cells were collected and immunostained with antibodies against CD133 and nestin. Results RFP-SU2 cells grew as levitated sphere with high RFP expression; the transfection efficiency of SU2 cell before transfection was only 1.5%, while that of 20-passaged RFP-SU2 cells after transfection reached to 75%. RFP-SU2 single cell could proliferate into brain tumor stem cell spheres, having the abilities of self-renewing and clonal proliferation. Immunofluorescence showed positive- CD133 and nestin expressions in RFP-SU2 cells. Conclusion A SU2/RFP cell line marked by RFP is established; and it can serve as a promising tool for further basic research.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2012年第7期737-740,共4页 Chinese Journal of Neuromedicine
基金 江苏省卫生厅135重点学科建设基金(XK(200722) 苏州市科技计划项目(SYS201025)
关键词 胶质瘤干细胞 慢病毒 红色荧光蛋白 Glioma stem cell Lentivirus Red fluorescent protein
  • 相关文献

参考文献4

二级参考文献67

  • 1Thompson MC Fuller C Hogg TL Dalton J Finkelstein D Lau CC Chintagumpala M Adesina A Ashley DM KeUie SJ Taylor MD Curran T Gajjar A Gilbertson RJ.Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations[J].中国神经肿瘤杂志,2006,4(1):18-18. 被引量:17
  • 2Clement V Sanchez P de Tribolet N Radovanovic I Ruiz i Altaba A.HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity[J].中国神经肿瘤杂志,2007,5(2):122-122. 被引量:97
  • 3Folkman J.What is the evidence that tumors are angiogenesis dependent? J Nail Cancer Inst 1990; 82:4-6.
  • 4Gasparini G,Harris AL.Clinical importance of the determination of tumor angiogenesis in breast carcinoma:much more than a new prognostic tool.J Clin Oncol 1995; 13:765-782.
  • 5Ferrara N.Vascular endothelial growth factor.The trigger for neovascularization in the eye.Lab Invest 1995; 72:638-645.
  • 6Omuro AM,Delattre JY.Editorial:what is new in the treatment of gliomas? Cuff Opin Neurol 2007; 20:704-707.
  • 7Lassman AB,Holland EC.Incorporating molecular tools into clinical trials and treatment for gliomas? Curt Opin Neurol 2007; 20:708-711.
  • 8Hida K,Hida Y,Shindoh M.Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies.Cancer Sci 2008; 99:459-466.
  • 9Qiang L,Yang Y,You QD,Ma YJ,Yang L,Nie FF,et al.Inhibition of glioblastoma growth and angiogenesis by gambogic acid:An in vitro and in vivo study.Biochem Pharmacol 2008; 75:1083-1092.
  • 10Denekamp J.Endothelial cell proliferation as a novel approach to targeting turnout therapy.Br J Cancer 1982; 45:136-139.

共引文献40

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部